To Study the Effect of Aprocitentan on the Electrical Activity of the Heart in Healthy Men and Women

NCT04281342 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Aprocitentan 25 mg
DRUG: Aprocitentan 100 mg
DRUG: Matching placebo
OTHER: Moxifloxacin control to establish assay sensitivity

Sponsor

Idorsia Pharmaceuticals Ltd.